Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

NCT05677724 is registered in ClinicalTrials.gov with Fubing Wang as lead sponsor.

NCT NCT05677724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
Lead sponsor
Fubing Wang
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
June 30, 2023
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv, primary liver cancer